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Abstract
We propose the name nucleotide pyrophosphatases/phosphodiesterases (NPP) for the enzymes that release nucleoside-5P-
monophosphates from various pyrophosphate and phosphodiester bonds. Three structurally related mammalian NPPs are
known, i.e. NPPK (autotaxin), NPPL (B10/gp130RB13ÿ6) and NPPQ (PC-1). We report here that these isozymes have a distinct
tissue distribution in the rat but that they are all three expressed in hepatocytes. In FAO rat hepatoma cells only the level of
NPPQ was stimulated by TGF-L1. In rat liver, the concentration of the transcripts of all three isozymes was found to increase
manyfold during the first weeks after birth, but the increased expression of the NPPK mRNA was transient. The level of the
NPP transcripts transiently decreased after hepatectomy, but NPPK mRNA was also lost after sham operation, which
suggests that it may belong to the negative acute-phase proteins. The loss of the L- and Q-transcripts after hepatectomy was
not due to a decreased NPP gene transcription or an increased turnover of the mature transcripts. However, hepatectomy
also caused a similar loss of the nuclear pool of the NPPL and NPPQ mRNAs. We conclude that a deficient processing and/or
an increased turnover of the NPP pre-mRNAs underlies the hepatectomy-induced decrease of the L- and Q-transcripts. A
similar loss of nuclear NPPQ mRNA was also noted after treatment with cycloheximide, indicating that protein(s) with a high
turnover control the stability and/or processing of the immature NPPQ transcript. ß 1999 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Type I phosphodiesterases (EC 3.1.4.1) were orig-
inally described as enzymes that generate nucleoside-
5P-monophosphates from a variety of oligonucleo-
tides and nucleotide derivatives, as opposed to the
type II phosphodiesterases, which release nucleo-
side-3P-monophosphates [1]. However, the latter en-
zymes are now classi¢ed as 3P-exonucleases (EC
3.1.16) and, instead, the name ‘phosphodiesterase
II’ is now often used to denote a structurally unre-
lated subgroup of cyclic nucleotide phosphodiester-
ases [2]. Moreover, it has been established that type I
phosphodiesterases can also hydrolyse phosphoanhy-
dride bonds and are identical to the enzymes that
have been classi¢ed as nucleotide pyrophosphatases
(EC 3.6.1.9) [3]. To avoid a double and confusing
nomenclature, we propose to name these enzymes
henceforward nucleotide pyrophosphatases/phospho-
diesterases (NPP). They release nucleoside-5P-mono-
phosphates from various pyrophosphate bonds (in
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e.g. nucleoside diphosphates and triphosphates,
NAD, FAD, UDP-glucose) and phosphodiester
bonds (in oligonucleotides and arti¢cial substrates
like the p-nitrophenyl ester of TMP).
Three structurally related mammalian NPPs are
known that are encoded by di¡erent genes. These
isozymes have all been discovered in a di¡erent con-
text and for none of them their function as an NPP
was clear from the beginning, which explains their
inconsistent and illogical nomenclature (Table 1).
NPPK or autotaxin was discovered as a protein
that is secreted by melanoma cells and stimulates
cell motility [4]. A splice variant of NPPK cloned
from a rat brain library was named phosphodiester-
ase IK [5]. NPPL was initially described as
gp130RB13ÿ6, i.e. a plasma membrane glycoprotein
of 130 kDa that is recognized by the monoclonal
antibodies RB13-6, which visualize a subpopulation
of neural precursor cells that are sensitive to malig-
nant conversion by N-ethyl-N-nitrosourea [6]. More
recently, it has been reported that the latter protein is
identical to B10, a membrane protein on the apical
surface of hepatocytes [7]. The same isozyme was
also independently cloned from a prostate library
and named phosphodiesterase IL [8]. The best
studied NPP is the one we now term the Q-isozyme,
which was initially discovered as a surface marker of
antibody-secreting B-lymphocytes, hence the name
plasma-cell di¡erentiation antigen-1 (PC-1) [9]. It is
now known, however, that NPPQ is expressed in a
large variety of tissues, including the liver, where it is
present on the basolateral surface of the hepatocytes
[7]. NPPQ has been implicated in the control of var-
ious processes such as extracellular nucleotide metab-
olism [10], protein glycosylation [11] and insulin sig-
nalling [12], although conclusive evidence for these
functions is lacking.
NPPs are transmembrane proteins, but for all
three isozymes there also appear to exist soluble
and secreted forms that are generated by proteolysis
[9,13]. The NPPs in the plasma membrane consist of
a short N-terminal intracellular domain, a single
transmembrane domain and a large extracellular
C-terminal domain that contains the catalytic NPP
site. A fraction of NPPQ is present in the membranes
of the endoplasmic reticulum, where its C-terminal
domain faces the lumen of the endoplasmic reticulum
[3,14].
The activity and expression of NPPs are tightly
regulated. NPPK [15] and NPPQ [10,16] are inacti-
vated by autocatalytic phosphorylation at submicro-
molar concentrations of ATP. This inactivation re-
sults from phosphorylation of the same active site
Thr that also forms a covalent, nucleotidylated inter-
mediate during the pyrophosphatase/phosphodiester-
ase reaction. Re-activation of NPPQ results from nu-
cleotide-stimulated autodephosphorylation [10,16].
This autoregulatory mechanism of NPPK and NPPQ
may prevent the hydrolysis of extracellular nucleo-
tides when they become scarce. The expression of
NPPs is tightly controlled by growth factors and
hormones. NPPK is downregulated by interferon-Q
in ¢broblasts [17]. In smooth muscle cells, the
NPPL transcript level is decreased by PDGF and
angiotensin II [18]. The expression of NPPQ in osteo-
sarcoma cells and chondrocytes, but not in ¢bro-
blasts, was reported to be stimulated by TGF-L1
and, in chondrocytes, this e¡ect was antagonized
by interleukin-1L [19,20]. NPPQ in osteosarcoma cells
and T-lymphocytes is induced by agents that activate
protein kinase A or C [21,22]. We have previously
reported that the expression of NPPQ in rat liver is
growth-related, i.e. the level of NPPQ increases dra-
matically during the ¢rst weeks after birth and is
transiently decreased following a 70% hepatectomy
[14]. It has also been reported that the level of
NPPL in rat serum increases substantially following
bile duct ligation and during the development of
cholangiocarcinoma, probably as a result of proteo-
lytic cleavage of the membrane-associated form [13].
We show here that all three NPP isozymes are
expressed in rat hepatocytes and that their expression
in the liver is di¡erentially regulated. In addition, we
report that the transient loss of the NPPL and NPPQ
mRNAs during liver regeneration is due to a de-
Table 1
Nomenclature of mammalian nucleotide pyrophosphatases/
phosphodiesterases
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creased processing and/or an increased lability of
their precursors.
2. Materials and methods
Full-length NPPK cDNA from a human breast
adenocarcinoma cell line (MDA-MB-435) and
NPPL cDNA from rat brain were gifts from Dr.
M. Stracke (Bethesda, MD, USA) and Dr. H. Deiss-
ler (Essen, Germany), respectively. Hepatocytes were
isolated from normally fed rats as described by Bol-
len et al. [23]. A 70% hepatectomy, involving the
removal of the large median and left lateral liver
lobes, was performed under ether anaesthesia on
Wistar rats weighing approx. 200 g [14]. Sham sur-
gery consisted of the same manipulations except that
the liver was left intact.
Total RNA was isolated from freeze-clamped liv-
ers by CsCl centrifugation [24]. For the experiment
illustrated in Fig. 6, the livers were ¢rst fractionated
by the citric acid method of Miller [25], with slight
modi¢cations. Brie£y, 2 g of liver was homogenized
in 20 ml of a bu¡er containing 75 mM citric acid at
pH 2.3, 0.25 M sucrose and 0.5% (v/v) Triton X-100.
The homogenate was layered on top of two cushions,
the ¢rst one containing 10 ml of 25 mM citric acid at
pH 2.3, 1.8 M sucrose and 0.1% Triton X-100, and
the second one containing 5 ml of 75 mM citric acid
at pH 2.3, 1 M sucrose and 0.5% Triton X-100. Fol-
lowing centrifugation for 75 min at 25 000Ug, the
nuclear pellet was resuspended in 50 mM citric acid
at pH 2.3, 0.25 M sucrose, 40% (w/v) glycerol, 0.5%
Triton X-100 and washed three times in this bu¡er.
RNAs from the homogenates and the nuclei were
prepared by the CsCl method [24]. All other materi-
als and experimental procedures were as described
previously [14].
3. Results and discussion
3.1. Tissue distribution of NPPs
Northern blot analysis of various rat tissues re-
vealed a quite di¡erent distribution of the three
NPP isozymes (Fig. 1). A single NPPK transcript of
3.5 kb was detected, which was predominantly ex-
pressed in brain, lung, duodenum and adrenals.
However, the NPPK mRNA was also clearly present
in rat liver. Our results agree with those of Narita et
al. [5], who found a single transcript in various rat
brain regions, but are at variance with those of Fuss
et al. [26], who detected several NPPK transcripts in
rat tissues, including a much smaller ‘liver-speci¢c’
species. We found that the NPPL transcript (3.0
kb) was scarce in brain and adrenals, but abundant
in liver, heart, kidney and duodenum (Fig. 1). The
NPPQ-cDNA hybridized in rat tissues with two tran-
scripts (4.1 and 3.2 kb) that were mainly present in
liver, heart and kidney. Remarkably, the testis ex-
pressed L- and Q-transcripts that were considerably
smaller than those in other tissues, which indicates
the existence of testis-speci¢c splice variants.
Northern analysis of RNA from either total liver
or freshly isolated hepatocytes showed that the
mRNAs encoding all three NPPs are present in hep-
atocytes at a similar relative abundance as in intact
liver (Fig. 2). However, in FAO rat hepatoma cells
only NPPL and NPPQ were expressed.
Fig. 1. Northern blot analysis in rat tissues. Each lane contains
30 Wg of total RNA isolated from the indicated tissues. The
blot was consecutively hybridized with full-length cDNAs en-
coding NPPK, NPPL, NPPQ and 18S rRNA, the latter to ascer-
tain equal loading. In between the blot was dehybridized each
time in 0.5% SDS at 95‡C for 15 min. Dehybridization was
veri¢ed by autoradiography.
BBAMCR 14464 21-4-99
C. Stefan et al. / Biochimica et Biophysica Acta 1450 (1999) 45^52 47
3.2. Regulation of the expression of NPPs
As has already been shown for NPPQ in bone and
cartilage cells [19,20], we found that the expression of
the Q-isozyme in FAO cells was stimulated by TGF-
L1 (Fig. 2B). In contrast, the expression of the K-
and L-isozymes was not a¡ected by this growth fac-
tor. The addition of TGF-L1, i.e. 3 ng/ml (0.1 nM)
for 24 h increased the level of NPPQ mRNA (Fig.
2A) and protein (Fig. 2B) by 2- and 4-fold, respec-
tively, as compared to the corresponding conditions
without the growth factor. It is also shown in Fig. 2B
that a prolonged incubation per se already resulted
in an increased level of NPPQ protein, in agreement
with the report that the concentration of NPPQ in
FAO cells increases with the cell density [14].
cAMP and the phorbol ester PMA, which have
been shown to increase the level of NPPQ in T-lym-
phocytes and osteosarcoma cells through activation
of protein kinases A and C, respectively [21,22], did
not a¡ect the expression of NPPQ in FAO hepatoma
cells within 24 h (not shown).
The expression of the NPP mRNAs in rat liver
was also found to be age-related (Fig. 3). All isozyme
mRNAs were present at birth but their levels in-
creased severalfold during the ensuing weeks. The
NPPK transcript level increased only transiently dur-
ing the ¢rst weeks after birth and returned to neo-
natal levels after 5^6 weeks. The concentration of the
NPPL transcript increased quite abruptly between
2 and 3 weeks of age and remained stable thereafter.
The level of the NPPQ transcript was very low at
birth, but increased gradually between birth and
3 weeks of age, as reported previously [14].
We have also used liver regeneration after 70%
hepatectomy as a model to study the growth-related
expression of NPPs (Fig. 4). The level of all NPP
transcripts decreased manyfold after partial hepatec-
tomy, similarly to what we demonstrated previously
for NPPQ [14]. The minimal NPP mRNA levels were
Fig. 2. The expression of NPPs in hepatocytes and FAO cells.
(A) Northern blots with total RNA (30 Wg/lane) from rat liver,
freshly isolated hepatocytes or cultured FAO rat hepatoma
cells. Also shown is the e¡ect of an incubation of FAO cells
with 3 ng/ml TGF-L1 for 24 h on the NPP mRNA level. Gen-
eral procedure as described in the legend to Fig. 1. (B) E¡ect
of an incubation of FAO cells for up to 48 h, in the absence or
presence of TGF-L1, on the level of NPPQ, as revealed by West-
ern analysis with NPPQ-speci¢c antibodies.
Fig. 3. The expression of NPP isozymes in the liver of neonatal
and young rats. The ¢gure shows Northern blots with total
RNA (30 Wg/lane) that was isolated from the liver of rats of
the indicated age. All blots were prepared with RNA from the
same series of livers.
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reached 16^20 h after hepatectomy. At 20 h the levels
of the K-, L- and Q-transcripts were decreased by
90 þ 8%, 73 þ 11% and 74 þ 12% (n = 3), respectively.
The NPP transcript concentrations gradually nor-
malized during the ensuing 2 weeks, when liver re-
generation became nearly complete. Sham operation
did not signi¢cantly a¡ect the level of the NPPQ and
NPPL transcripts but, unexpectedly, caused an
equally important decrease in the level of the
NPPK transcript as did hepatectomy. This shows
Fig. 4. The e¡ects of sham operation or 70% hepatectomy on the NPP transcript levels. Rats were sacri¢ced at the indicated times
after sham surgery or partial hepatectomy and the hepatic NPP mRNA concentrations were estimated by Northern blot analysis (30
Wg total RNA/lane).
Fig. 5. E¡ects of inhibitors of protein synthesis on the level of NPP mRNAs. Rats were injected for the indicated times with actino-
mycin D (2 mg/kg body weight; i.p.) plus K-amanitin (0.5 mg/kg body weight; i.v.) or with cycloheximide (50 mg/kg body weight;
i.p.). Northern blot analysis with the indicated probes was done on total RNA (30 Wg/lane). Each blot was prepared with RNA from
the same series of animals.
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that the loss of NPPK was not associated with the
regeneration process itself but is most likely caused
by the acute-phase response, which represents the
early set of reactions to in£ammatory or stressful
stimuli, such as surgery [27^30]. Therefore, NPPK
may belong to the negative acute-phase proteins,
i.e. a group of intrahepatic or plasma proteins that
are downregulated during the acute-phase response.
This is in accordance with the report that NPPK in
¢broblasts is downregulated by interferon-Q, which
has anti-in£ammatory properties [17]. In further
agreement with this view, it should be noted that
the time course of downregulation of the NPPK tran-
script after sham operation (Fig. 4) is similar to that
of other negative acute-phase proteins [27,28]. Re-
markably, the restoration of the NPPK transcript
level in sham-operated animals was reproducibly
much slower than in the hepatectomized rats and
remained incomplete after 2 weeks. A similar disso-
ciation of the curves describing mRNA levels in
acute-phase and regenerating liver has been observed
for other proteins [28].
We have previously demonstrated that the steady-
state level of the NPPQ transcripts decreases rapidly
following the in vivo administration of the transla-
tional inhibitor cycloheximide, but is not a¡ected
within 8 h by the injection of the transcriptional in-
hibitors actinomycin D plus K-amanitin [14]. In Fig.
5 it is shown that this also applies to NPPK. Indeed,
both the NPPK and NPPQ transcripts gradually dis-
appeared after the administration of cycloheximide,
with an estimated half-life of 1^3 h. On the other
hand, the NPPL transcript was not a¡ected within
8^9 h by the inhibitors of protein synthesis. Collec-
tively, these data indicate that the half-life of the
NPP transcripts is rather long (s 10 h), but that
the maintenance of the NPPK and NPPQ transcripts
depends on protein(s) with a high turnover.
3.3. Cycloheximide and hepatectomy also a¡ect
nuclear NPP mRNA
Partial hepatectomy did not a¡ect the transcrip-
tion rates of the NPPL (not illustrated) and NPPQ
genes [14], as revealed by nuclear run-on assays.
Moreover, the level of the remaining NPPL and
NPPQ transcripts at 16 h after partial hepatectomy
was not further decreased by the administration of
Fig. 6. The e¡ects of partial hepatectomy or cycloheximide on the total and nuclear levels of the NPPL and NPPQ transcripts. Total
RNA (30 Wg/lane) was prepared both from liver homogenates and from nuclei that were isolated from the same homogenates, as de-
tailed in Section 2. The RNA was obtained from control rats and from animals that either had undergone a partial hepatectomy 20 h
earlier or had been intraperitoneally injected with cycloheximide (50 mg/kg body weight) 6 h previously.
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actinomycin D plus K-amanitin for up to 8 h (not
shown), indicating that the e¡ect of hepatectomy
cannot be explained by an increased turnover of
these mRNAs. On the other hand, the level of the
L- and Q-transcripts was a¡ected similarly in the total
and nuclear pools of RNA by partial hepatectomy or
by an injection with cycloheximide (Fig. 6). This in-
dicates that these treatments did not cause a de¢-
ciency in the nucleocytoplasmic transport of L- and
Q-transcripts, which should have resulted in their ac-
cumulation in the nucleus. Collectively, the above
data suggest that a nuclear event underlies the hep-
atectomy-induced loss of the NPPL and NPPQ tran-
scripts and most likely involves an increased turnover
and/or a de¢cient processing of their pre-mRNAs.
The same conclusion may apply to the loss of
NPPQ transcript after the administration of cyclohex-
imide.
4. Conclusions
We showed here that all three members of the
mammalian NPP family are present in rat hepato-
cytes (Figs. 1 and 2), but that their expression is
di¡erentially regulated. Thus, the expression of the
three isozymes increased substantially during the
hepatic growth phase in the ¢rst weeks after birth,
albeit with a di¡erent time course (Fig. 3), showing
that their expression is controlled by di¡erent stim-
uli. Conversely, the three NPP transcripts were tran-
siently lost during liver regeneration following 70%
hepatectomy (Figs. 4 and 6). For the NPPL and
NPPQ mRNAs this loss appears to be accounted
for by an intranuclear post-transcriptional process,
involving the stability or processing of the immature
transcripts. On the other hand, NPPK was also
downregulated following sham surgery (Fig. 4),
which suggests that NPPK represents a negative
acute-phase protein and that its expression is con-
trolled by anti-in£ammatory agents. We also ob-
served that the NPPK and NPPQ transcripts, in con-
trast to the NPPL transcript, rapidly decreased after
the administration of cycloheximide (Fig. 5), indicat-
ing that the stability of the K- and Q-transcripts is
controlled by one or more proteins with a short
half-life.
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